名稱 | β-thalassemia mutation Reference Standard Ⅲ |
型號 | CBPD0003 |
報價 | |
特點 | β-thalassemia mutation Reference Standard Ⅲ |
產(chǎn)品搜索
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 增強腫瘤免疫療法新靶點:ADORA2B(腺苷A2B受體)
- 細(xì)胞株有關(guān)細(xì)胞培養(yǎng)污染的控制
- 可視化觀察黑色素瘤早期轉(zhuǎn)移,鑒定出一種新的治療靶標(biāo)
- 細(xì)胞株培養(yǎng)傳代時的指數(shù)增生期解讀
- 聚焦靶點BRAF——BRAF相關(guān)突變細(xì)胞強勢登場
- LTβR信號通路誘導(dǎo)三級淋巴結(jié)構(gòu)的形成,促進(jìn)趨化因子的表達(dá)
- Western Blot標(biāo)準(zhǔn)操作流程
- atcc細(xì)胞培養(yǎng)紫外燈照射的目的與實踐
- 川大華西CRISPR研究再獲新進(jìn)展
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0003β-thalassemia mutation Reference Standard Ⅲ
- 詳細(xì)內(nèi)容
Introduction | |
Format | Genomic DNA |
Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
Technical Data | |
Mutation 1 | Variation site: -87(C>G) |
DNA Change: N/A | |
Zygosity: Heterozygous | |
Allelic Frequency: 50% | |
Chr position(GRCh37): Chr11.5248388C>G | |
Transcript: NM_000518.5 | |
Mutation 2 | Variation site: IVS-I-110(G>A) |
DNA Change: c.93-21G>A | |
Zygosity: Homozygous | |
Allelic Frequency: 100% | |
Chr position(GRCh37): Chr11.5248050C>T | |
Transcript: NM_000518.5 | |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Figure 1. -87(C>G) Heterozygous Figure 2. IVS-I-110(G>A) Homozygous |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |